Estado funcional y calidad de vida en pacientes latinoamericanos con esquizofrenia tratados con un antipsicótico atípico o típico: resultado de 12 meses del estudio Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO). / [Functional status and quality of life in Latin American outpatients with schizophrenia treated with atypical or typical antipsychotics: outcomes of the 12 months schizophrenia outpatient health outcomes (IC-SOHO) Study]
Vertex
; 16(63): 332-41, 2005 Sep-Oct.
Article
en Es
| BINACIS
| ID: bin-38365
Biblioteca responsable:
AR81.4
ABSTRACT
OBJECTIVE:
Functional status and quality of life outcomes in Latin American outpatients with schizophrenia were compared after 12 months of monotherapy treatment with olanzapine, risperidone or typical antipsychotics.METHOD:
Both outcomes were assessed as part of a prospective, large (N= 7658), international (27 countries), observational study.RESULTS:
from the Latin American subpopulation (N= 2671; 11 countries) are presented. Compared to typical antipsychotics, olanzapine and risperidone were associated with significantly (p < 0.05) greater odds of employment and social activity, and significantly greater improvements in quality of life. Olanzapine was also associated with significantly greater odds of living independently, compared to typical antipsychotics.CONCLUSION:
This study indicates that functional status and quality of life outcomes are likely to be more favorable when Latin American outpatients with schizophrenia are treated with olanzapine or risperidone monotherapy, rather than typical antipsychotics.
Buscar en Google
Colección:
06-national
/
AR
Base de datos:
BINACIS
Tipo de estudio:
Observational_studies
Aspecto:
Patient_preference
Idioma:
Es
Revista:
Vertex
/
Vertex rev. argent. psiquiatr
Año:
2005
Tipo del documento:
Article
Pais de publicación:
Argentina